Who Owns Tango Therapeutics Stock?
NASDAQ: TNGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 127.11%
- Institutions (% of float)
- 128.62%
- Held by insiders
- 1.18%
- Institutional holders
- 353
- Institutions 98.8%
- Insiders 1.2%
- Public and other 0.0%
Who owns Tango Therapeutics stock?
Institutional investors own about 127.1% of Tango Therapeutics's shares, spread across 353 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.18% of TNGX.
The largest institutional holders are RTW Investments LP (8.29%), FMR, LLC (7.76%) and Blackrock Inc. (7.76%). Together, the top 10 institutions control 57.5% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their TNGX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TNGX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RTW Investments LP | 14.05M | 8.29% | +1.1% |
| FMR, LLC | 13.15M | 7.76% | +6.6% |
| Blackrock Inc. | 13.14M | 7.76% | +5.7% |
| Goldman Sachs Group Inc | 11.41M | 6.73% | +14.3% |
| Boxer Capital Management, LLC | 10.53M | 6.21% | -3.2% |
| State Street Corporation | 7.32M | 4.32% | +22.3% |
| Adage Capital Partners GP L.L.C. | 7.26M | 4.28% | +29.6% |
| Paradigm Biocapital Advisors LP | 6.96M | 4.11% | +9.5% |
| Siren, L.L.C. | 6.78M | 4.00% | +9.8% |
| TCG Crossover Management, LLC | 6.77M | 4.00% | -25.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TNGX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.40M | 2.59% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 4.07M | 2.40% |
| iShares Trust-iShares Russell 2000 ETF | 3.65M | 2.15% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.82M | 1.66% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.82M | 1.66% |
| T. Rowe Price New Horizons Fund, Inc. | 1.55M | 0.91% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.54M | 0.91% |
| T. Rowe Price Health Sciences Fund, Inc. | 1.40M | 0.83% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.37M | 0.81% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.32M | 0.78% |
Frequently asked questions
Who is the largest shareholder of Tango Therapeutics?
RTW Investments LP is the largest institutional shareholder of TNGX, owning 8.29% of shares outstanding (14.05M shares) as of its latest 13F filing.
What percentage of Tango Therapeutics is owned by institutions?
Institutions own about 127.1% of TNGX shares and 128.6% of the public float.
How much of Tango Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.18% of TNGX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.